PURPOSE: Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The present study aimed to analyse the prognostic impact of HIF-1alpha and MT expression in colorectal cancer and to evaluate a possible link of combined HIF-1alpha and MT expression with colorectal cancer progression. MATERIALS AND METHODS: We investigated the relationship of HIF-1alpha and MT with each other and clinicopathological parameters including proliferative activity (Ki67) and apoptosis (terminal desoxyribonucleotide transferase-mediated dUTP nick-end labelling) using immunohistochemistry. RESULTS: HIF-1alpha expression was identified as an independent prognostic parameter in multivariate survival analysis and characterised an aggressive cancer phenotype. In addition, HIF-1alpha was significantly linked to an increased expression of MT. CONCLUSIONS: HIF-1alpha expression qualified as an independent prognostic and characterised an aggressive cancer phenotype associated with an increased expression of MT. Our study suggests that MT can be added to the complex biological pathways induced by hypoxia in human cancer tissue.
PURPOSE:Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The present study aimed to analyse the prognostic impact of HIF-1alpha and MT expression in colorectal cancer and to evaluate a possible link of combined HIF-1alpha and MT expression with colorectal cancer progression. MATERIALS AND METHODS: We investigated the relationship of HIF-1alpha and MT with each other and clinicopathological parameters including proliferative activity (Ki67) and apoptosis (terminal desoxyribonucleotide transferase-mediated dUTP nick-end labelling) using immunohistochemistry. RESULTS:HIF-1alpha expression was identified as an independent prognostic parameter in multivariate survival analysis and characterised an aggressive cancer phenotype. In addition, HIF-1alpha was significantly linked to an increased expression of MT. CONCLUSIONS:HIF-1alpha expression qualified as an independent prognostic and characterised an aggressive cancer phenotype associated with an increased expression of MT. Our study suggests that MT can be added to the complex biological pathways induced by hypoxia in humancancer tissue.
Authors: P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe Journal: Nature Date: 1999-05-20 Impact factor: 49.962
Authors: P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe Journal: Science Date: 2001-04-05 Impact factor: 47.728
Authors: T Dalton; B C Paria; L P Fernando; Y M Huet-Hudson; S K Dey; G K Andrews Journal: Comp Biochem Physiol B Biochem Mol Biol Date: 1997-01 Impact factor: 2.231
Authors: E T Donnelly; H Bardwell; G A Thomas; E D Williams; M Hoper; P Crowe; W G McCluggage; M Stevenson; D H Phillips; A Hewer; M R Osborne; F C Campbell Journal: Br J Cancer Date: 2005-06-20 Impact factor: 7.640
Authors: Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Natsumi Irahara; Andrew T Chan; Jeffrey A Meyerhardt; Daniel C Chung; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino Journal: Am J Pathol Date: 2010-04-02 Impact factor: 4.307
Authors: Mohammad Namdarghanbari; William Wobig; Susan Krezoski; Niloofar M Tabatabai; David H Petering Journal: J Biol Inorg Chem Date: 2011-08-07 Impact factor: 3.358
Authors: Jarmila Kruseova; David Hynek; Vojtech Adam; Rene Kizek; Richard Prusa; Jan Hrabeta; Tomas Eckschlager Journal: Int J Mol Sci Date: 2013-06-06 Impact factor: 5.923